FCGR2B and anaphylaxis: As FcγRIII is an activating receptor whereas FcγRIIB is an inhibitory receptor, IgG-mediated passive systemic anaphylaxis (PSA) is reduced in FcRIII−/− mice and is enhanced in FcRIIB−/− mice [61].